Corporate Corruption News Stories

Excerpts of Key Corporate Corruption News Stories in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: This comprehensive list of news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

AAA asked the U.S. Senate Tuesday to investigate why oil companies are making huge profits at a time when glitches at gas refineries have caused pump prices to soar. "We are concerned about the number and frequency of refinery outages this year in light of the large profits the industry has been reporting," AAA Public Affairs Director Geoff Sundstrom told the Senate Committee on Energy and Natural Resources. "AAA doesn't know why refiners appear to be failing at this task, but we do think it would be worth the committee's time and trouble to find out." Sundstrom spoke at a Senate hearing at which lawmakers asked energy experts to explain the spell of unplanned refinery shutdowns that have thrown gas supplies into disarray from coast to coast, boosting average pump prices to a record $3.09 per gallon in the United States. California Energy Commission spokesman Bob Aldrich said his agency does not investigate the industry but does track its practices. This year the big story was a series of glitches in the annual switchover from winter gas to a differently formulated summer gas. Tom Kloza, publisher of the Oil Price Information Service ... said the surprise this year was that refineries outside California also had unplanned problems with their normal spring maintenance. "I did not think we'd see the same downtime elsewhere in the country," he said. Sean Comey, spokesman for AAA of Northern California, said the gas refining business is unusual because it seems that even when production goes down, prices and profits go up. "When most industries have production problems, profits suffer as a result," he said.

Senators who raised millions of dollars in campaign donations from pharmaceutical interests secured industry-friendly changes to a landmark drug-safety bill. The bill, which passed 93-1, grants the Food and Drug Administration broad new authority to monitor the safety of drugs after they are approved. It addressed some shortcomings that allowed the painkiller Vioxx to stay on the market for years after initial signs that it could cause heart attacks. However, the powers granted to the FDA in the bill's original version were pared back during private meetings. And efforts to curb conflicts of interest among FDA advisers and allow consumers to buy cheaper drugs from other countries were defeated in close votes. A measure that blocked an effort to allow drug importation passed, 49-40. The 49 senators who voted against drug importation received about $5 million from industry executives and political action committees since 2001 — nearly three quarters of the industry donations to current members of the Senate. Sen. Bernie Sanders, I-Vt. [was] the lone vote against the bill. "You have a culture in which big money has significant influence. Big money gains you access, access gives you the time to influence people." The pharmaceutical companies spend more money on lobbying than any other single industry — $855 million from 1998 to 2006. The biggest drug trade group, Pharmaceutical Research and Manufacturers of America, praised the bill after it passed. The group's spokesman, Ken Johnson, said its critics "never point out that a great deal of this money is spent trying to defeat bills … that are designed to cripple this industry."

Note: For lots more reliable, verifiable information on drug company manipulations, click here.

At Bob Oyster's Shell station ... putting the price way up over $4 a gallon isn't about making a profit. It's about making a statement to a multinational corporation. After Shell forced him to pay higher prices for gas in San Francisco and jacked up his rent, Oyster says, he decided to fight back. Far from making a huge profit, Oyster is going out of business. He has operated the Shell station at Sixth and Harrison for 22 years, but he's walking away from it at the end of the month. "I'm getting nothing for the station,'' he says. At a time when the oil companies are posting record profits, the little guys are struggling to stay in business. And many, like Oyster, are giving up the fight. "The dealer can no longer be competitive,'' says Dennis DeCota, executive director of the California Service Station and Automotive Repair Association. "The companies are squeezing these guys out. It's just wrong.'' Oyster says his rent has gone up exponentially. Fifteen years ago it was $1,000 a month. Then it went to $6,000, then $8,000. This year Shell came back with a demand of $13,000. DeCota and Oyster see [a] sinister motive: If the dealers like them leave, a company like Shell can run its stations with its own employees and set its own pump prices. "That way they really are controlling it from the well head to the gas pump,'' says DeCota. While the price per gallon gets all the attention, Oyster says the little secret of independent dealers is that, like movie theater operators, they make their profit on the extras -- snacks, drinks and other items.

Note: When the big oil boys supposedly believe in the "trickle down" theory, why are they not sharing any of their huge profits with their dealers? And why is there so little reporting on the arbitrary raising of gas prices?

Two of the world’s largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. The payments give physicians an incentive to prescribe the medicines at levels that might increase patients’ risks of heart attacks or strokes. At just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. [A] report prepared by F.D.A. staff scientists said no evidence indicated that the medicines either improved quality of life in patients or extended their survival. Several studies suggested that the drugs can shorten patients’ lives when used at high doses. The medicines ... are among the world’s top-selling drugs. They represent the single biggest drug expense for Medicare. Since 1991 ... the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing — and profits. The companies have [failed] to test whether lower doses of the medicines might work better than higher doses. There is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients.

Note: For lots more on major corruption in health care, click here.

Food safety experts have advised parents to eliminate a series of additives from their children's diet while they await the publication of a new study that is understood to link these ingredients to behaviour problems in youngsters. The latest scientific research into the effect of food additives on children's behaviour is thought to raise fresh doubts about the safety of controversial food colourings and a preservative widely used in sweets, drinks and processed foods. It will be several months before the results are published, despite the importance of the findings for children's health. Researchers at Southampton University have tested combinations of synthetic colourings and preservative that an average child might consume in a day to measure what effect they had on behaviour. A source at the university [said] their results supported findings first made seven years ago that linked the additives to behavioural problems, such as temper tantrums, poor concentration and hyperactivity, and to allergic reactions. Independent experts say that consumers should consider removing these additives from their children's diets now. Dr Alex Richardson, the director of Food and Behaviour Research and senior research scientist at Oxford University, said: "There are well-documented potential risks from these additives. In my view the researchers had done an excellent piece of work first time round and there was enough evidence to act. If this new study essentially replicates that, what more evidence do they need to remove these additives from children's food and drink?"

Note: For how drug companies collude with government to suppress this kind of information, click here.

The syrupy poison, diethylene glycol, is an indispensable part of the modern world, an industrial solvent and prime ingredient in some antifreeze. It is also a killer. And the deaths, if not intentional, are often no accident. Over the years, the poison has been loaded into all varieties of medicine — cough syrup, fever medication, injectable drugs — a result of counterfeiters who profit by substituting the sweet-tasting solvent for a safe, more expensive syrup, usually glycerin, commonly used in drugs, food, toothpaste and other products. Toxic syrup has figured in at least eight mass poisonings around the world in the past two decades. Researchers estimate that thousands have died. In many cases, the precise origin of the poison has never been determined. But records and interviews show that in three of the last four cases it was made in China, a major source of counterfeit drugs. Panama is the most recent victim. Last year, government officials there unwittingly mixed diethylene glycol into 260,000 bottles of cold medicine — with devastating results. Families have reported 365 deaths from the poison, 100 of which have been confirmed so far. Panama’s death toll leads directly to Chinese companies that made and exported the poison as 99.5 percent pure glycerin.

The United States and the European Union have signed up to a new transatlantic economic partnership at a summit in Washington. The pact is designed to boost trade and investment by harmonising regulatory standards, laying the basis for a US-EU single market. The two sides agreed to set up an "economic council" to push ahead with regulatory convergence in nearly 40 areas, including intellectual property, financial services, business takeovers and the motor industry. The aim is to increase trade and lower costs. Some reports suggest that incompatible regulations in the world's two richest regions add 10% to the cost of developing and producing new cars.

Note: Why is this important news getting such minimal press coverage?

The ties between doctors and drug manufacturers are close indeed. Most physicians (94 percent) reported some type of relationship with the pharmaceutical industry ... according to [a] study, published in the April 26 issue of the New England Journal of Medicine. Most of these relationships involved receiving food in the workplace (83 percent) or receiving drug samples (78 percent). More than one-third of the respondents (35 percent) were reimbursed for costs associated with professional meetings or continuing medical education, while more than one-quarter (28 percent) were paid for consulting, delivering lectures or enrolling patients in clinical trials. Over the past two decades, physician-industry relationships have attracted increasing scrutiny. One review found that, on average, physicians meet with industry representatives four times a month, and medical residents accept six gifts annually from industry representatives. "We know that these relationships have benefits and risks, and we know that they benefit the companies that are involved, and we know from our data that they benefit doctors," said study author Eric G. Campbell, an assistant professor of health care policy at the Institute for Health Policy at Harvard Medical School. "The real question is to what extent do these relationships benefit patients, and the answer is, we don't know." Campbell said that he found it hard to believe that free football tickets for a doctor would trickle down to benefit patients.

Note: For an excellent article by one of the foremost doctors in the nation on how the pharmaceutical industry has corrupted politics and damaged our health, click here.

We couldn't pass up mention of the winner of last week's Eco-marathon Americas, a fuel-economy challenge sponsored by Shell Oil Co. A team from Cal Poly San Luis Obispo won the $10,000 grand prize by achieving the equivalent of 1,902.7 miles per gallon on regular gasoline in a student-built vehicle. Granted, the students didn't win in someone's mom's Dodge minivan. Their "car" is a one-occupant streamliner built of carbon fiber composite. At a measly 98 pounds, it weighed less than the driver. And that was 98 pounds including the car's 50-cubic-centimeter Honda engine. "The main reason we do this is because it's a way to encourage students to focus on technical innovation for potential future careers," said David Sexton, president of Shell Oil Products. But there is a practical side to the competition, said Cal Poly team manager Tom Heckel, a junior mechanical engineering major. "Any publicity we can get makes people aware that the 20 mpg or so they're averaging in their cars can be improved on — a lot." The event, held April 14 at the California Speedway in Fontana, was the first time that Shell had brought its 25-year-old Eco-marathon competition to the U.S. The event drew 20 university, college and high school teams from around the U.S. and Canada. Rules called for each vehicle to complete seven 1.45-mile laps around the speedway's inner track, averaging at least 15 mph. Fuel consumption was measured after each attempt and adjusted for ambient temperature and other factors in a complex formula that ends up giving an extrapolation of miles per gallon.

Note: Why would the president of Shell Oil Products state the main reason for this competition is about careers and not finding ways to improve gas mileage? The world record is over 10,000 mpg. How is it that the average car gets only 22 mpg when the Ford Model T got 25 mpg almost 100 years ago? For more, click here.

Ryan Mickle's life was the stuff young bourgeois dreams are made of. Then a year ago ... Mickle began to take stock of his life. He was earning a lot of money but was giving very little of himself. So Mickle ditched his high-paying job to brainstorm a new venture with friend Rod Ebrahimi. The result was Dotherightthing.com, a San Francisco startup that allows users to rank companies based on their social impact on the world. Their site [allows] consumers to influence corporate behavior. The sentiment is summed up in Dotherightthing.com's T-shirt slogan: "It's cool to care." Mickle, 26, and Ebrahimi, 25, are among a growing number of entrepreneurs betting they can build ventures that deliver both financial and social returns. EBay founder Pierre Omidyar has dedicated much of his fortune to helping for-profits and nonprofits alike discover their power to do good. At www.freepledge.com, shoppers buy the same products from the same merchants for the same price, but a percentage is donated to the nonprofit of their choice. Darian Hickman, 28, is designing an online strategy game that turns the players into entrepreneurs who help bring prosperity to impoverished villages in underdeveloped countries. [He was] inspired by Muhammad Yunus, the Nobel prize-winning micro-finance pioneer. Premal Shah [is a] former PayPal executive who is president of online micro-lender Kiva.org. Brian Johnson, 32 ... said he felt uncomfortable with capitalism until he hit on the concept of "using economics as a force for good. How do we live our spiritual ideals and make money?" Now Johnson tries to have it both ways with Zaadz.com, which he describes as MySpace for people who want to change the world.

Note: We encourage you to take some time to explore some of these exciting new adventures which are transforming the face of business and building a brighter future for us all. For more on micro-finance, micro-lending, and how you can help end poverty without donating a penny, click here. And for the profile of website founder Fred Burks on Zaadz.com, click here.

The March 16 recall of 91 pet food products manufactured by Menu Foods wasn't big news at first. Early coverage reported only 10-15 cats and dogs dying. I'm a contributing editor for a nationally syndicated pet feature ... and all of us there have close ties to the veterinary profession. What we were hearing from veterinarians wasn't matching what we were hearing on the news. Although ... Menu Foods started getting complaints as early as December 2006, FDA records state the company received their first report of a food-related pet death on February 20. One week later, on February 27, Menu started testing the suspect foods. Three days later, on March 3, the first cat in the trial died of acute kidney failure. Nearly one month passed from the date Menu got its first report of a death to the date it issued the recall. At that point, Menu had seen a 35 percent death rate in their test-lab cats. We started a database for people to report their dead or sick pets. As of March 31, the number of deaths alone was at 2,797. Pet owners were encouraged to report deaths and illness to the FDA. But ... there was no place on the agency's Web site to do so. The FDA kept confirming a number it had to have known was only the tip of the iceberg. It prevented veterinarians from having the information they needed to treat their patients. It allowed the media to repeat a misleadingly low number ... preventing a lot of people from really grasping the scope and implication of the problem. An import alert buried on the FDA Web site ... identified the Chinese company that is the source of the contaminated gluten -- gluten that is now known to be sold not only for use in animal feed, but in human food products, too.

Note: If you want to understand how the FDA sometimes works to support big industry at the expense of our health (and in this case the health of our pets), the entire article is a big eye-opener. Click here for more.

If you have ever wondered why the cost of prescription drugs in the United States are the highest in the world or why it's illegal to import cheaper drugs from Canada or Mexico, you need look no further than the pharmaceutical lobby and its influence in Washington, D.C. Congressmen are outnumbered two to one by lobbyists for an industry that spends roughly a $100 million a year in campaign contributions and lobbying expenses to protect its profits. One reason [drug company] profits have exceeded Wall Street expectations is the Medicare prescription drug bill ... passed three-and-a-half years ago. The unorthodox roll call on one of the most expensive bills ever placed before the House of Representatives began in the middle of the night. The only witnesses were congressional staffers, hundreds of lobbyists, and U.S. Representatives like Dan Burton, R-Ind., and Walter Jones, R-N.C. "The pharmaceutical lobbyists wrote the bill," says Jones. Why did the vote finally take place at 3 a.m.? "They didn't want on national television in primetime," according to Burton. "I've been in politics for 22 years," says Jones, "and it was the ugliest night I have ever seen." Jones says the arm-twisting was horrible. It certainly wasn't ugly for the drug lobby which ... has been a source of lucrative employment opportunities for congressmen when they leave office. In all, at least 15 congressional staffers, congressmen and federal officials left to go to work for the pharmaceutical industry, whose profits were increased by several billion dollars. "They have unlimited resources," Burton says. "And when they push real hard to get something accomplished in the Congress of the United States, they can get it done."

Note: This article also states that the Medicare prescription bill "was the largest entitlement program in more than 40 years, and the debate broke down along party lines." Usually Republicans are against entitlement programs while Democrats support them. Why was it the opposite in this case? Could it be that big industry made huge profits from the passage of this bill? For lots more, click here.

Income inequality grew significantly in 2005, with the top 1 percent of Americans — those with incomes that year of more than $348,000 — receiving their largest share of national income since 1928. The top 10 percent, roughly those earning more than $100,000, also reached a level of income share not seen since before the Depression. While total reported income in the United States increased almost 9 percent in 2005, the most recent year for which such data is available, average incomes for those in the bottom 90 percent dipped slightly compared with the year before, dropping $172, or 0.6 percent. The gains went largely to the top 1 percent, whose incomes rose to an average of more than $1.1 million each, an increase of more than $139,000, or about 14 percent. The new data also shows that the top 300,000 Americans collectively enjoyed almost as much income as the bottom 150 million Americans. The top group received 440 times as much as the average person in the bottom half earned, nearly doubling the gap from 1980. The disparities may be even greater. The [IRS] estimates that it is able to accurately tax 99 percent of wage income but that it captures only about 70 percent of business and investment income, most of which flows to upper-income individuals. For Americans in the middle, the share of income taken by federal taxes has been essentially unchanged across four decades. By comparison, it has fallen by half for those at the very top of the income ladder. [Incomes of] the top tenth of a percent and top one-hundredth of a percent ... soared by about a fifth in one year, largely because of the rising stock market and increased business profits.

France's famous high-speed train, the TGV, broke its 17-year-old world speed record today when it hit a top speed of 357.2 mph. Another French train held the previous rail train record, set in 1990, of 320.2 mph. Normal TGV trains have a cruising speed of 186 mph. Japan holds the absolute speed record for a train, with its magnetically levitated Maglev train that floats over a guideway on a magnetic field without ever touching the track. The Maglev set a record of 361 mph in 2003.

Note: A CNN report states that the fastest train in the U.S. is the Acela, with a top speed of 150 mph. The same report notes "the top speed for most passenger trains outside the Northeast Corridor ... is 79 mph." Another CNN article comments "Japan's Shinkansen trains, introduced just before the 1964 Tokyo Olympics, regularly hit 186 mph." Why are American trains so backward compared to the rest of the world? Could it have anything to do with oil? For more, click here.

Hal Taussig wears baggy jeans and fraying work shirts that Goodwill might reject. His shoes have been resoled three times. At age 81, he doesn't own a car. He performs errands and commutes to the office by bicycle. And he has given away millions. Given the fortune that Taussig has made through Untours, his unique travel business, and has given away through the Untours Foundation, you could call him the Un-millionaire. If he so chose, he could be living in a Main Line mansion and driving a Mercedes. But he considers money and what he calls "stuff," beyond what he needs to survive, a burden, an embarrassment. In many respects, he's a 21st-century Thoreau. "Let your capital be simplicity and contentment," the sage of Walden Pond wrote. "Those are my sentiments precisely," says Taussig, who has three children, five grandchildren, and five great-grandchildren. He directs the Untours Foundation, into which he pours all his profits - $5 million since 1992. The money is used to make low-interest loans to ventures and projects that help the needy and jobless - from a craft store in Hanoi to a home-health-care cooperative in Philadelphia. "I invest in entrepreneurial efforts to help poor people leverage themselves out of poverty." "In America, we worship success," he says. "It's a shoddy ethic that leads us to value who we are by what we are." The motto of the Untours Foundation is "a hand up, not a handout." It provides low-interest loans, here and abroad, to create jobs, build low-income housing, and support fair-trade products: goods such as coffee that are sold at a price that guarantees producers and workers a fair wage and decent livelihood.

Note: For an easy way you can use your investments to help families pull out of poverty, click here.

Richard Cotta, CEO of California Dairies Inc., the nation's second-largest dairy cooperative, is guided by a simple business philosophy: "If you want milk with little blue dots, you'll have it, as long as you are willing to pay for it." So, when a string of major customers, including supermarket giant Safeway, came to his co-op saying they would no longer accept milk from cows treated with a genetically engineered growth hormone, the co-op bowed to the inevitable. In January, California Dairies' board voted to ask its members not to inject synthetic bovine growth hormone into their cows. The action by a co-op that ships 50 million pounds of milk every day is part of a sweeping, consumer-driven agricultural makeover. Demand for natural foods is rising, while increasing numbers of consumers are avoiding products that rely on antibiotics or growth hormones. And food retailers are listening. Recombinant bovine somatotropin, or rbST, was approved by the Food and Drug Administration 14 years ago. It sustains lactation by stimulating cows' appetites so they eat more and produce more milk, perhaps an extra 5 quarts per day. The European Union, Japan, Canada and Australia did not approve rbST. The reasons included questions about human and animal safety, as well social and economic considerations. Research that shows injections of rbST increase another hormone, insulin-like growth factor 1, or IGF-1, in cows. Too much IGF-1 in humans is linked with increased rates of colon, breast and prostate cancer. Synthetic hormone use also ... leads to increased use of antibiotics, whose overuse is already a serious problem in the livestock industry.

Note: For many years the media has avoided even mentioning the major controversy over growth hormone use in milk and other animal products. To better understand how the mass media and big industry sometimes work together for profit at the expense of your health, click here.

When you buy a gallon of organic milk, you expect to get tasty milk from happy cows who haven't been subjected to antibiotics, hormones or pesticides. But you might also unknowingly be getting genetically modified cattle feed. Albert Straus, owner of the Straus Family Creamery ... decided to test the feed that he gives his 1,600 cows last year and was alarmed to find that nearly 6% of the organic corn feed he received from suppliers was "contaminated" by genetically modified (GM) organisms. Organic food is, by definition, supposed to be free of genetically modified material. But as GM crops become more prevalent, there is little that an organic farmer can do to prevent a speck of GM pollen or a stray GM seed from being blown by the wind onto his land. In 2006, GM crops accounted for 61% of all the corn planted in the U.S. and 89% of all the soybeans. So Straus and five other natural food producers, including industry leader Whole Foods, announced last week that they would seek a new certification for their products, "non-GMO verified," in the hopes that it will become a voluntary industry standard for GM-free goods. In a few weeks, Straus expects to become the first food manufacturer in the country to carry the label in addition to his "organic" one. With Whole Foods in the ring, the rest of the industry will soon be under competitive pressure to follow. Genetically modified crops have become so prevalent in the U.S. that chances are you've been buying and eating them for years. You just wouldn't know it from the label: the U.S. Department of Agriculture, unlike agencies in Europe and Japan, do not require GM foods to be labeled.

Note: This article also states "scientists have not identified any specific health risks from eating GM foods." This is a clear lie, when two sentences later the article mentions Jeffrey Smith, who has written an entire book with excellent documentation showing many scientific studies in which animals died shortly after consuming GM foods. To see an excellent summary of this book including reliable footnotes, click here.

Dr. Allan Collins ... is president of the National Kidney Foundation. In 2004 ... the pharmaceutical company Amgen, which makes the most expensive drugs used in the treatment of kidney disease, underwrote more than $1.9 million worth of research and education programs led by Dr. Collins. In 2005, Amgen paid Dr. Collins at least $25,800, mostly in consulting and speaking fees. The payments to Dr. Collins and the research center ... come from Minnesota, the first of a handful of states to pass a law requiring drug makers to disclose payments to doctors. The Minnesota records are a window on the widespread financial ties between pharmaceutical companies and the doctors who prescribe and recommend their products. From [1997] through 2005, drug makers paid more than 5,500 doctors, nurses and other health care workers in the state at least $57 million. More than 100 people received more than $100,000. Research shows that doctors who have close relationships with drug makers tend to prescribe more, newer and pricier drugs — whether or not they are in the best interests of patients. Drug companies “want somebody who can manipulate in a very subtle way,” said Dr. Frederick R. Taylor. Kathleen Slattery-Moschkau, a former sales representative [said] “it all comes down to ways to manipulate the doctors.” Some of the doctors receiving the most money sit on committees that prepare guidelines instructing doctors nationwide about when to use medicines. “It is critical that the experts who write clinical guidelines be prohibited from having any conflicts of interest,” said Dr. Marcia Angell, a former editor of The New England Journal of Medicine.

Note: This article only scratches the surface of legal and illegal corruption by the powerful pharmaceutical industry. If you care about who really controls our health system, don't miss Dr. Marcia Angell's incredibly revealing essay showing the unbelievable wealth and influence of the drug companies available here.

The Bush Administration has run a systematic campaign to play down the dangers of climate change, demanding hundreds of politically motivated changes to scientific reports and muzzling a pre-eminent expert on global warming, the US Congress has been told. The testimony ... painted the Administration as determined to maintain its line on climate change even when it clashed with the findings of scientific experts. The Administration has moved to exercise control over environmental agencies by installing political appointees including a former oil industry lobbyist, Philip Cooney, as chief of staff of the Council on Environmental Quality. In 2003 Mr Cooney and other senior appointed officials made at least 181 changes to a strategic plan on climate change to play down the scientific consensus on global warming. They made a further 113 alterations to minimise the human role in climate change. "These changes must be made," a note in Mr Cooney's handwriting says. Under heated questioning, Mr Cooney admitted the changes were all intended to cast doubt on the impact of global warming. Control from the White House became the norm, [NASA's Dr. James] Hansen told the committee. "Scientific press releases were going to the White House for editing," he said. "It's very unfortunate that we developed this politicisation of science. The public relations office should be staffed by expert appointees - otherwise they become offices of propaganda." Hansen was also restrained from giving press interviews by a junior political appointee, George Deutsch. Mr Deutsch left NASA early last year after it emerged he had falsified his CV.

The Pentagon has said it, the President has said it, everybody says it: "Our troops deserve nothing but the best when we send them into combat." It’s a goal that isn’t always met. Did a retired Marine colonel’s connections count more than the best design for a new vehicle for the troops? Jerry Bazinski has made a career of designing and helping to develop new vehicles here in Detroit for years. So when the Marines called for new vehicle small enough to load into an Osprey helicopter but lean and mean enough to allow soldiers to move quickly and launch attacks deep into enemy territory, Jerry and a team of veteran Detroit vehicle designers came up with [a model that] met or exceeded all the specifications. It was designed to provide for bullet-proof protection from enemy gunfire. It included a sturdy built-in roll-cage. And the Marines were impressed, as you can see from the report card that shows a whole list of many strengths ... and "no significant weaknesses." Well, here’s what the Marines ultimately bought ... a model known as the Growler that sort of looks like a dune buggy with a machine gun. Though it may seem it should have a lower sticker price, it’s turned out to cost us upwards of $127,000 a copy. Former Colonel Terry Crews ... sold the Marines on the Growler. [Investigative Reporter Steve] Wilson to Wayne Blake/Growler Plant Manager: That’s how he got this contract, he had some friends, didn’t he? Blake: Yeah, he lives 15 miles from the Pentagon. And the military version is $127,000. And if you bought it as a civilian version? 17,000.

Note: This article has disappeared from the website, though you can try this Google cache version. For a highly revealing, two-page summary by a top U.S. general on major war corruption, click here.

Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.